G
68.39
2.47 (3.75%)
| Previous Close | 65.92 |
| Open | 65.72 |
| Volume | 482,081 |
| Avg. Volume (3M) | 763,947 |
| Market Cap | 2,935,065,600 |
| Price / Sales | 16.79 |
| Price / Book | 1.17 |
| 52 Weeks Range |
| Operating Margin (TTM) | -482.59% |
| Diluted EPS (TTM) | -59.59 |
| Quarterly Revenue Growth (YOY) | 19.10% |
| Total Debt/Equity (MRQ) | 2.67% |
| Current Ratio (MRQ) | 9.70 |
| Operating Cash Flow (TTM) | -464.88 M |
| Levered Free Cash Flow (TTM) | -236.88 M |
| Return on Assets (TTM) | -11.98% |
| Return on Equity (TTM) | -62.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | GRAIL, Inc. | Mixed | Bullish |
AIStockmoo Score
0.9
| Analyst Consensus | -2.0 |
| Insider Activity | 1.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.90 |
|
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| % Held by Insiders | 14.18% |
| % Held by Institutions | 66.50% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHASE WILLIAM J | 63.74 | - | 5,491 | 349,996 |
| KREVANS SARAH | 63.74 | - | 5,491 | 349,996 |
| MIZELL STEVEN | 63.74 | - | 5,491 | 349,996 |
| SUMME GREGORY L | 63.74 | - | 5,491 | 349,996 |
| Aggregate Net Quantity | 21,964 | |||
| Aggregate Net Value ($) | 1,399,985 | |||
| Aggregate Avg. Buy ($) | 63.74 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KREVANS SARAH | Director | 18 Jun 2026 | Acquired (+) | 5,491 | 63.74 | 349,996 |
| SUMME GREGORY L | Director | 18 Jun 2026 | Acquired (+) | 5,491 | 63.74 | 349,996 |
| CHASE WILLIAM J | Director | 18 Jun 2026 | Acquired (+) | 5,491 | 63.74 | 349,996 |
| MIZELL STEVEN | Director | 18 Jun 2026 | Acquired (+) | 5,491 | 63.74 | 349,996 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |